Presentation ESC 2017 Validation of the European Society of Cardiology 0/1-Hour Algorithm for Rule-out and Rule-in of Acute Myocardial Infarction Presenter: Raphael Twerenbold September 08, 2017
News Conference News ESC 2017 Acute MI Mortality Has Dropped to Very Low Levels in France Todd Neale September 08, 2017
News Conference News ESC 2017 ESC Algorithm for Rapidly Diagnosing NSTEMI Works, Study Confirms Todd Neale September 08, 2017
News Conference News ESC 2017 DAPT Can Be Safely De-Escalated Post-PCI Based on Platelet Function Testing Todd Neale September 07, 2017
News Conference News ESC 2017 Inclisiran Offers Sustained LDL-Lowering Through 1 Year: ORION-1 Michael O'Riordan September 05, 2017
News Conference News ESC 2017 ESC Releases Revamped DAPT Guidance Focusing on Personalized Approach Todd Neale September 01, 2017
News Conference News ESC 2017 Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI Shelley Wood September 01, 2017
News Conference News ESC 2017 Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets Michael O'Riordan August 30, 2017
Presentation ESC 2017 Undertreatment of Female Patients in Lipid-Lowering for Secondary Prevention in Europe, Canada, South Africa, Middle East and China Presenter: Anselm K. Gitt August 30, 2017
News Conference News ESC 2017 CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS Todd Neale August 30, 2017
News Conference News ESC 2017 P2Y12 Inhibitor Pretreatment Questioned in STEMI Todd Neale August 29, 2017
Presentation ESC 2017 Guidelines for the Management of Acute Myocardial Infarction in Patients presenting with ST-Segment Elevation Presenter: Borja Ibanez August 28, 2017
Presentation ESC 2017 DETermination of the role of OXygen in suspected Acute Myocardial Infarction Presenter: Robin Hofmann August 28, 2017
News Conference News ESC 2017 Supplemental Oxygen Provides No Benefit to Patients With Suspected MI: DETO2X-AMI Michael O'Riordan August 28, 2017
Presentation ESC 2017 PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease Presenter: Martin J. Holzmann August 28, 2017
Presentation ESC 2017 Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial Presenter: Robert Giugliano August 28, 2017
News Conference News ESC 2017 Ultra-Low LDL Levels? FOURIER Suggests Efficacy of Evolocumab Michael O'Riordan August 28, 2017
News Conference News ESC 2017 Dual Antithrombotic Approach in Patients With A-fib Undergoing PCI Boosted in RE-DUAL PCI Todd Neale August 27, 2017
News Conference News ESC 2017 ESC Updates Guidelines for Treating STEMI Patients Michael O'Riordan August 27, 2017
News Conference News ESC 2017 Latest Bivalirudin, Heparin Face-off in MI Cements Winner in Routine Practice: VALIDATE-SWEDEHEART Shelley Wood August 27, 2017